Which medicines are covered The PAP only covers a specific list of Novo Nordisk registered trademark medicines, which currently includes certain GLP-1 medications (Ozempic, Rybelsus and Xultophy), insulin products (Fiasp, Novolin R, Novolin N and Novolin 70/30, NovoLog Vial, NovoLog PenFill and Flexpen, NovoLog Mix, Tresiba), devices (Novopen, NovoFine), and other selected specialty therapies
Guo, S., & DiPietro, L
10.1186/s12964-023-01108-1 60 WangY.ZhengL.ShangW.YangZ.LiT.LiuF.et al (2022)
GLP-1 and glucagon display similar amino acid N-terminal sequences and bind to structurally related receptors, facilitating the development of single-molecule GLP-1R/GCGR co-agonists
Do not combine with other NSAIDs (e.g., ibuprofen, naproxen) unless advised by a healthcare professional